| 标题 |
High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cell Reports Medicine 作者:Huan Yan; Wenjuan Jiang; Yi Xiong; Li Liu; Renzhi Zhang; et al 出版日期:2026-07-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)